Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regorafenib in Pre-treated mCRC with RAS or BRAF Mutations (PREVIUM)
NCT02175654Phase 2Terminated
- Sponsor
- Spanish Cooperative Group for Digestive Tumour Therapy
- Start
- Jun 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of regorafenib in colorectal cancer (CRC), sponsored by Spanish Cooperative Group for Digestive Tumour Therapy. Started Jun 2014; status: terminated.
02
Drugs
regorafenib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02175654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02175654.